An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia
INTRODUCTION: The introduction of imatinib mesylate in 1998 has changed the management of chronic myeloid leukaemia. It is now the first-line therapy for newly diagnosed chronic myeloid leukaemia patients worldwide. However, its long-term survival benefit still needs to be established in clinical s...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/2983/ http://www.ncbi.nlm.nih.gov/pubmed/22252185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|